TrialCancer science2019

Carfilzomib monotherapy in Japanese patients with relapsed or refractory multiple myeloma: A phase 1/2 study.

Shinsuke Iida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.